Daijiro Hori, Takahiro Yamamoto, Takeshi Kakiuchi, Atsushi Yamaguchi
{"title":"术前血管功能障碍与心脏手术后急性肾损伤有关。","authors":"Daijiro Hori, Takahiro Yamamoto, Takeshi Kakiuchi, Atsushi Yamaguchi","doi":"10.21037/jtd-24-1291","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Cardiac surgery-associated acute kidney injury (CSA-AKI) results in poor prognosis. Several risk factors for CSA-AKI have been reported, including preoperative creatinine level, cardiopulmonary bypass time, and perioperative blood pressure management. Only few studies have reported the effect of vascular stiffness on the incidence of CSA-AKI, and there are is no study reporting on endothelial function and its association with CSA-AKI. The purpose of this study was to evaluate the association between preoperative vascular function, including vascular stiffness and endothelial function, and incidence of CSA-AKI.</p><p><strong>Methods: </strong>In this prospective observational study, 40 consecutive patients undergoing valve surgery were enrolled. Flow-mediated dilation (FMD) and pulse wave velocity (PWV) were measured before surgery for the evaluation of endothelial function and vascular stiffness. Blood test was also performed for the measurement of serum biomarkers including asymmetric dimethylarginine (ADMA) and vascular cell adhesion molecule-1 (VCAM-1). CSA-AKI was diagnosed by using the Kidney Disease Improving Global Outcomes (KDIGO) criteria.</p><p><strong>Results: </strong>The mean age of the patients was 72±8.2 years old and 60% were male. All patients underwent valve surgery with two patients undergoing concomitant coronary artery bypass grafting. Preoperative FMD and PWV were 6.3%±2.58% and 1,554±386.6 cm/s respectively. ADMA and VCAM-1 were significantly correlated (r=0.50, P=0.001), and there was a significant correlation between FMD and ADMA (r=-0.42, P=0.007), and FMD and VCAM-1 (r=-0.42, P=0.007). Eleven patients (27.5%) developed CSA-AKI. FMD was lower in patients with CSA-AKI (no AKI: 6.9%±2.57% <i>vs.</i> AKI: 4.6%±1.77%, P=0.009) and PWV was higher in patients with CSA-AKI (no AKI: 1,467±296.4 cm/s <i>vs.</i> AKI: 1,784±506.7 cm/s, P=0.02). Further, VCAM-1 was higher in patients with CSA-AKI (no AKI: 696±247.5 ng/mL <i>vs.</i> AKI: 879±196.2 ng/mL, P=0.03). Multivariable analysis showed that preoperative FMD was an independent risk factor for CSA-AKI (odds ratio: 0.54, P=0.049).</p><p><strong>Conclusions: </strong>VCAM-1, FMD, and PWV were associated with incidence of CSA-AKI. These measurements may be useful in evaluation of potential risk of CSA-AKI in patients undergoing valve surgery.</p>","PeriodicalId":17542,"journal":{"name":"Journal of thoracic disease","volume":"16 12","pages":"8271-8279"},"PeriodicalIF":2.1000,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11740064/pdf/","citationCount":"0","resultStr":"{\"title\":\"Preoperative vascular dysfunction is associated with acute kidney injury after cardiac surgery.\",\"authors\":\"Daijiro Hori, Takahiro Yamamoto, Takeshi Kakiuchi, Atsushi Yamaguchi\",\"doi\":\"10.21037/jtd-24-1291\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Cardiac surgery-associated acute kidney injury (CSA-AKI) results in poor prognosis. Several risk factors for CSA-AKI have been reported, including preoperative creatinine level, cardiopulmonary bypass time, and perioperative blood pressure management. Only few studies have reported the effect of vascular stiffness on the incidence of CSA-AKI, and there are is no study reporting on endothelial function and its association with CSA-AKI. The purpose of this study was to evaluate the association between preoperative vascular function, including vascular stiffness and endothelial function, and incidence of CSA-AKI.</p><p><strong>Methods: </strong>In this prospective observational study, 40 consecutive patients undergoing valve surgery were enrolled. Flow-mediated dilation (FMD) and pulse wave velocity (PWV) were measured before surgery for the evaluation of endothelial function and vascular stiffness. Blood test was also performed for the measurement of serum biomarkers including asymmetric dimethylarginine (ADMA) and vascular cell adhesion molecule-1 (VCAM-1). CSA-AKI was diagnosed by using the Kidney Disease Improving Global Outcomes (KDIGO) criteria.</p><p><strong>Results: </strong>The mean age of the patients was 72±8.2 years old and 60% were male. All patients underwent valve surgery with two patients undergoing concomitant coronary artery bypass grafting. Preoperative FMD and PWV were 6.3%±2.58% and 1,554±386.6 cm/s respectively. ADMA and VCAM-1 were significantly correlated (r=0.50, P=0.001), and there was a significant correlation between FMD and ADMA (r=-0.42, P=0.007), and FMD and VCAM-1 (r=-0.42, P=0.007). Eleven patients (27.5%) developed CSA-AKI. FMD was lower in patients with CSA-AKI (no AKI: 6.9%±2.57% <i>vs.</i> AKI: 4.6%±1.77%, P=0.009) and PWV was higher in patients with CSA-AKI (no AKI: 1,467±296.4 cm/s <i>vs.</i> AKI: 1,784±506.7 cm/s, P=0.02). Further, VCAM-1 was higher in patients with CSA-AKI (no AKI: 696±247.5 ng/mL <i>vs.</i> AKI: 879±196.2 ng/mL, P=0.03). Multivariable analysis showed that preoperative FMD was an independent risk factor for CSA-AKI (odds ratio: 0.54, P=0.049).</p><p><strong>Conclusions: </strong>VCAM-1, FMD, and PWV were associated with incidence of CSA-AKI. These measurements may be useful in evaluation of potential risk of CSA-AKI in patients undergoing valve surgery.</p>\",\"PeriodicalId\":17542,\"journal\":{\"name\":\"Journal of thoracic disease\",\"volume\":\"16 12\",\"pages\":\"8271-8279\"},\"PeriodicalIF\":2.1000,\"publicationDate\":\"2024-12-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11740064/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of thoracic disease\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.21037/jtd-24-1291\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/12/27 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"RESPIRATORY SYSTEM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of thoracic disease","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.21037/jtd-24-1291","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/12/27 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 0
摘要
背景:心脏手术相关急性肾损伤(CSA-AKI)预后较差。CSA-AKI的几个危险因素已被报道,包括术前肌酐水平、体外循环时间和围手术期血压管理。仅有少数研究报道血管僵硬度对CSA-AKI发病率的影响,内皮功能及其与CSA-AKI的关系尚无研究报道。本研究的目的是评估术前血管功能(包括血管硬度和内皮功能)与CSA-AKI发生率之间的关系。方法:在这项前瞻性观察研究中,纳入了40例连续接受瓣膜手术的患者。术前测量血流介导扩张(FMD)和脉搏波速度(PWV),评估内皮功能和血管硬度。同时进行血液检测,测定血清生物标志物,包括不对称二甲基精氨酸(ADMA)和血管细胞粘附分子-1 (VCAM-1)。CSA-AKI的诊断采用肾脏疾病改善总体预后(KDIGO)标准。结果:患者平均年龄72±8.2岁,男性占60%。所有患者均行瓣膜手术,其中2例患者同时行冠状动脉旁路移植术。术前FMD为6.3%±2.58%,PWV为1554±386.6 cm/s。ADMA与VCAM-1呈显著相关(r=0.50, P=0.001), FMD与ADMA呈显著相关(r=-0.42, P=0.007), FMD与VCAM-1呈显著相关(r=-0.42, P=0.007)。11例(27.5%)发生CSA-AKI。CSA-AKI患者FMD较低(无AKI: 6.9%±2.57% vs. AKI: 4.6%±1.77%,P=0.009), PWV较高(无AKI: 1467±296.4 cm/s vs. AKI: 1784±506.7 cm/s, P=0.02)。此外,CSA-AKI患者的VCAM-1较高(无AKI患者:696±247.5 ng/mL vs. AKI患者:879±196.2 ng/mL, P=0.03)。多变量分析显示术前FMD是CSA-AKI的独立危险因素(优势比:0.54,P=0.049)。结论:VCAM-1、FMD和PWV与CSA-AKI的发生率相关。这些测量可能有助于评估接受瓣膜手术的患者发生CSA-AKI的潜在风险。
Preoperative vascular dysfunction is associated with acute kidney injury after cardiac surgery.
Background: Cardiac surgery-associated acute kidney injury (CSA-AKI) results in poor prognosis. Several risk factors for CSA-AKI have been reported, including preoperative creatinine level, cardiopulmonary bypass time, and perioperative blood pressure management. Only few studies have reported the effect of vascular stiffness on the incidence of CSA-AKI, and there are is no study reporting on endothelial function and its association with CSA-AKI. The purpose of this study was to evaluate the association between preoperative vascular function, including vascular stiffness and endothelial function, and incidence of CSA-AKI.
Methods: In this prospective observational study, 40 consecutive patients undergoing valve surgery were enrolled. Flow-mediated dilation (FMD) and pulse wave velocity (PWV) were measured before surgery for the evaluation of endothelial function and vascular stiffness. Blood test was also performed for the measurement of serum biomarkers including asymmetric dimethylarginine (ADMA) and vascular cell adhesion molecule-1 (VCAM-1). CSA-AKI was diagnosed by using the Kidney Disease Improving Global Outcomes (KDIGO) criteria.
Results: The mean age of the patients was 72±8.2 years old and 60% were male. All patients underwent valve surgery with two patients undergoing concomitant coronary artery bypass grafting. Preoperative FMD and PWV were 6.3%±2.58% and 1,554±386.6 cm/s respectively. ADMA and VCAM-1 were significantly correlated (r=0.50, P=0.001), and there was a significant correlation between FMD and ADMA (r=-0.42, P=0.007), and FMD and VCAM-1 (r=-0.42, P=0.007). Eleven patients (27.5%) developed CSA-AKI. FMD was lower in patients with CSA-AKI (no AKI: 6.9%±2.57% vs. AKI: 4.6%±1.77%, P=0.009) and PWV was higher in patients with CSA-AKI (no AKI: 1,467±296.4 cm/s vs. AKI: 1,784±506.7 cm/s, P=0.02). Further, VCAM-1 was higher in patients with CSA-AKI (no AKI: 696±247.5 ng/mL vs. AKI: 879±196.2 ng/mL, P=0.03). Multivariable analysis showed that preoperative FMD was an independent risk factor for CSA-AKI (odds ratio: 0.54, P=0.049).
Conclusions: VCAM-1, FMD, and PWV were associated with incidence of CSA-AKI. These measurements may be useful in evaluation of potential risk of CSA-AKI in patients undergoing valve surgery.
期刊介绍:
The Journal of Thoracic Disease (JTD, J Thorac Dis, pISSN: 2072-1439; eISSN: 2077-6624) was founded in Dec 2009, and indexed in PubMed in Dec 2011 and Science Citation Index SCI in Feb 2013. It is published quarterly (Dec 2009- Dec 2011), bimonthly (Jan 2012 - Dec 2013), monthly (Jan. 2014-) and openly distributed worldwide. JTD received its impact factor of 2.365 for the year 2016. JTD publishes manuscripts that describe new findings and provide current, practical information on the diagnosis and treatment of conditions related to thoracic disease. All the submission and reviewing are conducted electronically so that rapid review is assured.